Georg Nebgen
Director/Miembro de la Junta en Kika Medical International Co. .
Perfil
Dr. Nebgen is a of NGN Capital.
He joined from MPM Capital where he had previously been Principal at MPM Capital in Boston and Managing Director of MPM Capital GmbH.
Prior to this, Dr. Nebgen was with Schering-Plough Corporation, as Managed Care Area Manager for New England.
His responsibilities included contracting the reimbursement of Schering-Plough’s ethical pharmaceutical products and services with managed care organizations as well as leading sales pull-through activities of the field forces.
Prior to this, Dr. Nebgen had served in Schering-Plough's subsidiary in Switzerland as Business Unit Head, Oncology & Biotech and Business Unit Head, Cardiovascular & CNS.
Dr. Nebgen joined Schering-Plough from F.
Hoffmann-La Roche, where he led as Technical Project Leader the global research & development team for Invirase/Fortovase its NDA filing, FDA approval, and subsequent product launch in the United States.
Dr. Nebgen obtained his doctorate in Pharmaceutical Technology Sciences from the University of Bonn, Germany and his executive MBA from the University of St. Gallen, Switzerland.
Cargos activos de Georg Nebgen
| Empresas | Cargo | Inicio |
|---|---|---|
Kika Medical International Co.
 Kika Medical International Co. Packaged SoftwareTechnology Services KIKA helps the world's most innovative biopharmaceutical and medical device organizations use advanced EDC solutions to bring much-needed medical solutions to market faster. KIKA's Veracity™ is the leading-edge Web-based clinical trial software platform that delivers Clinical Asset Management™ for any size clinical trial. Veracity is customized to meet study needs precisely. It provides unmatched flexibility and customization with advanced EDC including images and online adjudication. Veracity is backed by the industry's most reliable IT infrastructure and a world class Professional Services organization | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Georg Nebgen.
| Empresas | Cargo | Fin |
|---|---|---|
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 02/07/2010 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 21/04/2008 |
Mannesmann Plastics Machinery GmbH
 Mannesmann Plastics Machinery GmbH Industrial MachineryProducer Manufacturing Mannesmann Plastics Machinery GmbH manufactures plastics and rubber processing machines. It operates in three business divisions: Injection Moulding Technology, Reaction Technology, and Extrusion Technology. The firm offers extruders to produce TPE, silicone, rubber, and hybrid profiles, including extrusion, vulcanisation, and downstream equipment. The company was founded in 1998 and is headquartered in Munich, Germany. | Corporate Officer/Principal | - |
| German-American Business Council | Presidente | 01/01/2003 |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Director/Miembro de la Junta | - |
Formación de Georg Nebgen.
| University of St. Gallen | Masters Business Admin |
| University of Bonn | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| Empresas privadas | 15 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Distribution Services |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Health Technology |
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Finance |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
Kika Medical International Co.
Kika Medical International Co. Packaged SoftwareTechnology Services KIKA helps the world's most innovative biopharmaceutical and medical device organizations use advanced EDC solutions to bring much-needed medical solutions to market faster. KIKA's Veracity™ is the leading-edge Web-based clinical trial software platform that delivers Clinical Asset Management™ for any size clinical trial. Veracity is customized to meet study needs precisely. It provides unmatched flexibility and customization with advanced EDC including images and online adjudication. Veracity is backed by the industry's most reliable IT infrastructure and a world class Professional Services organization | Technology Services |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Retail Trade |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Kourion Therapeutics
 Kourion Therapeutics Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., Kourion Therapeutics is a German company that researches and develops initiatives for stem cell technology, used for the regeneration of cardiac, neuronal, hepatic, and bone tissues. The company is based in Dusseldorf, Germany. Kourion Therapeutics was acquired by ViaCell, Inc., part of Revvity, Inc. from November 16, 2007 on November 12, 2003. | Commercial Services |
Mannesmann Plastics Machinery GmbH
Mannesmann Plastics Machinery GmbH Industrial MachineryProducer Manufacturing Mannesmann Plastics Machinery GmbH manufactures plastics and rubber processing machines. It operates in three business divisions: Injection Moulding Technology, Reaction Technology, and Extrusion Technology. The firm offers extruders to produce TPE, silicone, rubber, and hybrid profiles, including extrusion, vulcanisation, and downstream equipment. The company was founded in 1998 and is headquartered in Munich, Germany. | Producer Manufacturing |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
Artisan Pharma, Inc.
 Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Artisan Pharma, Inc. provides critical-care and hospital-based therapeutics to patients. The firm focuses on the clinical development of drugs in the field of critical care therapeutics throughout the world. The company was founded by Kazuhisa Tsuruta in 2006 and is headquartered in Waltham, MA. | Health Services |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Health Technology |
Valtech Cardio Ltd.
 Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Valtech Cardio Ltd. develops devices for mitral valve repair and replacement. It specializes in the development of devices for mitral and tricuspid valve repair and replacement. The firm also offers full in-house development, manufacturing and clinical research capabilities, and patent applications. The company was founded by Amir Gross and Yossi Gross in March 2005 and is headquartered in Or Yehuda, Israel. | Health Technology |
| German-American Business Council |
- Bolsa de valores
- Insiders
- Georg Nebgen